Commerzbank Aktiengesellschaft FI Sells 4,908 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Commerzbank Aktiengesellschaft FI lowered its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 8.9% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 49,987 shares of the healthcare conglomerate’s stock after selling 4,908 shares during the quarter. Commerzbank Aktiengesellschaft FI’s holdings in UnitedHealth Group were worth $25,286,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Hudson Value Partners LLC lifted its stake in shares of UnitedHealth Group by 8.3% during the third quarter. Hudson Value Partners LLC now owns 1,069 shares of the healthcare conglomerate’s stock valued at $625,000 after acquiring an additional 82 shares during the period. Wealth Group Ltd. boosted its stake in shares of UnitedHealth Group by 4.0% in the 3rd quarter. Wealth Group Ltd. now owns 1,777 shares of the healthcare conglomerate’s stock valued at $1,039,000 after purchasing an additional 68 shares during the last quarter. Howard Capital Management Group LLC bought a new stake in shares of UnitedHealth Group during the third quarter worth approximately $341,000. GSG Advisors LLC boosted its stake in UnitedHealth Group by 14.4% in the third quarter. GSG Advisors LLC now owns 746 shares of the healthcare conglomerate’s stock valued at $435,000 after acquiring an additional 94 shares during the last quarter. Finally, Clear Creek Financial Management LLC lifted its stake in shares of UnitedHealth Group by 8.0% in the 3rd quarter. Clear Creek Financial Management LLC now owns 1,544 shares of the healthcare conglomerate’s stock valued at $903,000 after purchasing an additional 114 shares during the period. 87.86% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on UNH shares. Barclays dropped their price objective on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a report on Friday, January 17th. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research note on Tuesday, December 3rd. Piper Sandler cut their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. Cantor Fitzgerald restated an “overweight” rating and issued a $700.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. Finally, StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. One investment analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, UnitedHealth Group has an average rating of “Buy” and an average target price of $629.32.

UnitedHealth Group Price Performance

NYSE:UNH opened at $467.21 on Tuesday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The stock’s 50-day simple moving average is $515.81 and its 200 day simple moving average is $556.09. The company has a market cap of $429.97 billion, a P/E ratio of 30.14, a P/E/G ratio of 1.37 and a beta of 0.61. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same period in the previous year, the company earned $5.83 earnings per share. The firm’s revenue for the quarter was up 6.8% on a year-over-year basis. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th will be given a $2.10 dividend. The ex-dividend date of this dividend is Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.80%. UnitedHealth Group’s payout ratio is 54.19%.

Insider Buying and Selling

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the stock in a transaction on Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares in the company, valued at $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. 0.33% of the stock is owned by insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.